|
Mar. 08, 2019 |
|
|
May. 07, 2024 |
|
|
jRCTs052180103 |
Development and evaluation of chest functional examination technology with flat panel detector |
|
Development of dynamic X-ray inspection technology |
|
Mar. 21, 2024 |
|
378 |
|
378 subjects (270 males and 108 females) were included. Respiratory disease (obstructive pulmonary disease/interstitial lung disease, etc.), tumor diseases (lung tumor, etc.), and other diseases (cardiovascular disease, etc.) were 206, 156, and 16 cases, respectively. |
|
The number of subjects was increased as the research progressed, and 378 cases who underwent dynamic radiography were included in the analysis. |
|
Subjects' diseases, etc. (unfavorable changes in health (including abnormal laboratory test values), all serious adverse events, and deaths were not observed. |
|
1. The analysis of thoracic cage movement (especially posterior ribs) using dynamic chest radiographs has the potential to predict the severity of chronic obstructive pulmonary disease (COPD) and the risk of exacerbation. [Details] Twenty COPD patients underwent dynamic chest radiography analysis and were compared with controls with normal pulmonary function. The COPD stage according to Japanese guidelines was stage1:stage2:stage3:stage4 = 3:8:4:5, and the breakdown of GOLD classification based on symptoms, lung function, and exacerbation frequency was A:B:C:D = 4:8:3:5. The results showed that the thoracic movements of patients with severe COPD were abnormal, especially the movements of the lower posterior ribs, which tended to synchronize with the movements of the upper and middle ribs, unlike in normal cases. In the severe cases, there was decreased ventilation in the upper lung field. 2. The analysis of pulmonary blood flow mapping images obtained from dynamic chest radiographs has confirmed the possibility of evaluating pulmonary circulatory impairment indicated by decreased pulmonary diffusion capacity. [Details] Twenty-six patients with normal pulmonary function and COPD without obvious interstitial changes were included in the study. Comparisons were made between the DLco>=70% group (control group: n=15) and DLco<70% (reduced group: n=11), with pulmonary diffusion capacity (DLco) = 70%/predicted value as the cut-off value. Maximum Intensity Projection (MIP) of pulmonary blood flow mapping images was used as the pulmonary blood flow evaluation method. Results showed that MIP in the reduced group (0.48 plus-minus 0.086) was lower (p<0.05) than that in the control group (0.59 plus-minus 0.133), confirming the difference. |
|
The analysis of dynamic chest radiography (diaphragm and thorax movement, ventilation/ perfusion mapping images), which can be taken at the same cost, time, and exposure as the conventional initial X-ray examination, has confirmed the possibility of visually or partially quantitatively evaluating lung function and areas of impaired pulmonary ventilation/blood flow. |
|
May. 06, 2024 |
|
Oct. 26, 2020 |
|
https://doi.org/10.1002/acm2.13071https://doi.org/10.1002/rcr2.737 |
No |
|
No |
|
https://jrct.mhlw.go.jp/latest-detail/jRCTs052180103 |
Hasebe Terumitsu |
||
Tokai University Hachioji Hospital |
||
1838 Ishikawa-machi, Hachioji-shi, Tokyo, Japan |
||
+81-42-639-1111 |
||
hasebe@tokai-u.jp |
||
Hasebe Terumitsu |
||
Tokai University Hachioji Hospital |
||
1838 Ishikawa-machi, Hachioji-shi, Tokyo, Japan |
||
+81-42-639-1111 |
||
hasebe@tokai-u.jp |
Complete |
Jan. 04, 2018 |
||
| Jan. 04, 2018 | ||
| 410 | ||
Interventional |
||
single arm study |
||
open(masking not used) |
||
uncontrolled control |
||
single assignment |
||
diagnostic purpose |
||
The patient with respiratory diseases meets following conditions. |
||
1. Pregnancy |
||
| 20age old over | ||
| No limit | ||
Both |
||
respiratory diseases |
||
Dynamic imaging is performed for patients with respiratory diseases. |
||
Correlation coefficient between comparison objects for diaphragm motion range and change amount of average pixel value in lung field. |
||
The degree of agreement between ventilation/blood-flow mapping image and the gold standard. |
||
| KONICAMINOLTA,INC. | |
| Not applicable |
| Certified Review Board, Shiga University of Medical Science | |
| Seta Tsukinowa-cho, Otsu, Shiga | |
+81-77-548-3576 |
|
| hqrec@belle.shiga-med.ac.jp | |
| Approval | |
Feb. 12, 2019 |
none |